Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at Amsterdam UMC investigated ...

Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by ...

The National AIDS Commission (NAC) has raised serious concern over a steady increase in HIV cases across Liberia, revealing that the number of people living with the virus has climbed from 34,000 in ...

Funding for HIV care and prevention are key for continued progress, but recent cuts to federal funding for health agencies, ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...

In an article published in The Lancet HIV, authors including Distinguished Professor Denis Nash and Professor Constantin ...

The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...

Administration officials say South Africa has “significant means” to fund a promising new drug, lenacapavir, on its own.

Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...